Clinical Trials
7 trialsNCT03367247 2026-03-10
BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal
Dana-Farber Cancer Institute
Phase NA Completed
NCT04232384 2022-03-17
ROLLON
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase NA Terminated
NCT00326885 2018-10-17
Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites
Neovii Biotech
Phase 2 Completed
NCT02638051 2017-05-19
OTMA-RII
Galenic Research Institute Ltd
Phase 2 Completed
NCT02417753 2017-05-15
AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT02742428 2017-05-02
Preoperative Ascites Drainage Versus Standard Care for Patients With Advanced Ovarian Cancer
Gdynia Oncology Center
Phase NA Suspended
NCT00327444 2013-01-01
Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites
Sanofi
Phase 2/3 Completed